medicalxpress - Connor Murphy walked in circles around his dad, then flopped down on the kitchen floor, got up and walked in circles again.
#healthcare #publichealth #governmentpolicy #autism
Monday, February 16, 2026, 4:21 am / permalink 19235 / 8 stories in 28 days
oncodaily - Union for International Cancer Control (UICC) shared a post on LinkedIn: “The preliminary program for the World Cancer Congress 2026 – taking place in Hong Kong and hosted by UICC […]
#healthcare #publichealth #governmentpolicy #oncology
Monday, February 16, 2026, 2:22 am / permalink 19230 / 242 stories in 28 days
fiercehealthcare - The overhaul to the Hart-Scott-Rodino form went into effect in early 2025, and by the regulator's own estimates expanded merging companies' average paperwork burdens from 37 hours to 105 hours. The court's ordered rollback is set to take effect Feb. 19 pe…
#governmentpolicy #mergersandacquisitions #corporatetakeover
Monday, February 16, 2026, 12:21 am / permalink 19223 / 4 stories in 28 days
medicalxpress - Penn State College of Medicine is reporting on two cases of destructive infant meningitis linked to Paenibacillus infection, documenting severe neurologic injury and raising concerns about diagnosis and treatment. Reports from Uganda first linked these or…
#healthcare #publichealth #infanthealth
Monday, February 16, 2026, 12:21 am / permalink 19222 / 2 stories in 28 days
newscientist - Intermittent fasting appears to be no better than doing nothing when it comes to helping people who are overweight or have obesity lose weight
#obesity #healthcare #weightloss #publichealth
Monday, February 16, 2026, 12:21 am / permalink 19221 / 4 stories in 28 days
HIMSS 2026 pushes real‑time data, cloud and interoperability playbook 14 stories in 16.5 hours
Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma 3 stories in 17.5 hours
Vitamin D trial shows reduced long‑COVID risk but no severity benefit 2 stories in 19.5 hours
Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival 4 stories in 20.5 hours
FDA approves leucovorin for rare folate disorder despite autism hype 4 stories in 32.5 hours
HORMAD1 emerges as a potential target in triple‑negative breast cancer 4 stories in 45.5 hours
Alfasigma pays $300M to GSK for linerixibat rights, expanding liver-disease portfolio 2 stories in 48.5 hours
Roche’s hoped‑for breast cancer pill fails crucial first‑line trial 5 stories in 49.5 hours
Novo Nordisk and Hims bury the hatchet and carve a deal 3 stories in 54.5 hours
AI improves UK breast-screening detection by about 10% 5 stories in 54.5 hours
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.
Bluesky: